Xtant Medical Holdings (XTNT) Shares Outstanding (Weighted Average) (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $139.5 million in Q4 2025.

• Quarterly Shares Outstanding (Weighted Average) rose 4.39% year-over-year to $139.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $139.5 million (up 4.39% YoY) and the FY2025 annual result came in at $139.5 million, up 4.39% from the prior year.
• Shares Outstanding (Weighted Average) steadied at $139.5 million in Q4 2025 per XTNT's latest filing, from $139.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $139.5 million in Q4 2025 and bottomed at $81.2 million in Q1 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $114.0 million (2023), against an average of $112.2 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) soared 556.9%; it then rose 0.63% in 2022.
• Tracing XTNT's Shares Outstanding (Weighted Average) over 5 years: stood at $85.5 million in 2021, then increased by 10.1% to $94.1 million in 2022, then increased by 26.58% to $119.1 million in 2023, then climbed by 12.24% to $133.7 million in 2024, then climbed by 4.39% to $139.5 million in 2025.
• Per Business Quant, the three latest XTNT Shares Outstanding (Weighted Average) figures stand at $139.5 million (Q4 2025), $139.4 million (Q3 2025), and $139.2 million (Q2 2025).

Peer Comparison